MabPlex International
PrivateLast Round
Series B
Jun 8, 2020
Total Funding Raised
$130.1M
Company Overview
MabPlex International is a biotechnology company that provides comprehensive contract development and manufacturing organization (CDMO) services for biologics, including monoclonal antibodies and antibody-drug conjugates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MabPlex International Comparables
Compare MabPlex International with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiBo Biopharma Engineering Co., Ltd. | 88% | |
| Abzena | 87% | |
| WuXi Biologics | 86% |
MabPlex International Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2020 | ||||
| Series A | Jan 17, 2019 |
MabPlex International Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 德同资本 | Series B |
| OrbiMed | Series B |
| Huajin Capital | Series B |
| Sunshine Insurance Group | Series B |
| SDIC Venture Capital | Series A |
| Horus Capital | Series B |
| Shenzhen Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2020
$71M round led by Huajin Capital and DeTong Capital.
- Jan 17, 2019
$59.1M round led by SDIC Venture Capital and Shenzhen Capital Group
MabPlex International Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MabPlex International's valuation, stock price, and market status.
Is MabPlex International a public or private company?
MabPlex International is a private company.
What is the current stock price of MabPlex International?
MabPlex International is a private company, so its shares have no public market price. Caplight tracks MabPlex International's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MabPlex International worth (valuation)?
Valuation information for MabPlex International is not publicly available.
Can I buy MabPlex International stock?
MabPlex International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MabPlex International's last funding round?
MabPlex International's most recent funding round was Series B on June 8, 2020.
Who are the main investors in MabPlex International?
Key investors in MabPlex International include 德同资本, Huajin Capital, SDIC Venture Capital, Shenzhen Capital Group.
Will MabPlex International IPO soon?
No public IPO plans have been announced for MabPlex International.
How can I track MabPlex International secondary market activity?
Caplight tracks bids, offers, and trades in MabPlex International's shares on secondary markets.